Global Bilirubin Blood Test Market Research 2024, Forecast To 2033

The bilirubin blood test market has grown significantly in recent years, increasing from $1.26 billion in 2023 to $1.35 billion in 2024 at a compound annual growth rate (CAGR) of 7.1%. This growth can be attributed to the increasing prevalence of liver diseases, advancements in neonatal care, and rising health awareness. Additional factors include technological innovations, the development of healthcare infrastructure, regulatory approvals, and the growing adoption of point-of-care testing. Looking ahead, the bilirubin blood test market is expected to continue growing, reaching $1.78 billion in 2028 at a CAGR of 7.2%. Key drivers of growth during the forecast period include the rising demand for early diagnosis, the expansion of diagnostic laboratories, the increasing incidence of chronic diseases, and the growth of emerging markets. Major trends expected to shape the market include the development of non-invasive testing methods, the integration of digital health solutions, advancements in home testing kits, improvements in test accuracy and speed, personalized medicine approaches, smart diagnostic devices, and the development of portable testing devices.